Wolfgang Sieghart

Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation

Guobin He, Guann‐Yi Yu, Vladislav Temkin et al. · Cancer Cell · 2010 · 431 citations · Full text

Life Sciences, Cell Biology, Oncology +13

Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis

Mattias Mandorfer, Simona Bota, Philipp Schwabl et al. · Gastroenterology · 2014 · 371 citations

Medicine, Pharmacology, Pharmacotherapy +14

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

Lorenza Rimassa, Eric Assénat, Markus Peck‐Radosavljevic et al. · The Lancet Oncology · 2018 · 349 citations

Medicine, Oncology, Pharmacology +11

The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma

Wolfgang Sieghart, Florian Hucke, Matthias Pinter et al. · Hepatology · 2013 · 343 citations · Full text

Medicine, Oncology, Chemotherapy +16

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Mattias Mandorfer, K Kozbial, Philipp Schwabl et al. · Journal of Hepatology · 2016 · 301 citations

Life Sciences, Immunology, Infectious Diseases +16